Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2681

Actual shortage: 255 (10%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2417 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

23 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT CLARITHROMYCIN XL 500MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-11 2024-05-16 215737
TEVA-DILTIAZEM XC 240MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-11 2024-05-09 215740
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-11 2024-02-22 215743
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-11 2024-02-22 215746
TEVA-DILTIAZEM XC 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-18 2024-05-09 216466
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2024-02-08 2024-03-07 218983
TEVA-DILTIAZEM XC 360MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-07 2024-05-09 221546
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-18 2024-05-09 222572
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-28 2024-05-09 223856
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-28 2024-05-09 223862
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-05 2024-05-09 224445
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-04-18 2024-05-16 225492
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-05-16 2024-05-16 228143
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2017-08-01 2018-05-11 17844
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2019-09-26 2019-10-04 94825
TEVA-DICLOFENAC EC 25MG TABLET (ENTERIC-COATED) Avoided shortage 2019-11-21 2020-07-10 99453
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2020-03-26 2020-05-08 109583
TEVA-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2020-09-24 2020-10-22 124986
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-01-28 2021-04-08 132672
TEVA-5 ASA 400MG TABLET (ENTERIC-COATED) Resolved 2021-05-06 2021-06-10 138904

Showing 121 to 140 of 2681

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-QUININE 300MG CAPSULE Discontinued 2020-01-24 2020-01-24 104294
TEVA-TRANDOLAPRIL 0.5MG CAPSULE Discontinued 2020-07-10 2020-07-10 120021
TEVA-TRANDOLAPRIL 1MG CAPSULE Discontinued 2020-07-10 2020-07-10 120024
TEVA-TRANDOLAPRIL 2MG CAPSULE Discontinued 2020-07-10 2020-07-10 120027
TEVA-TRANDOLAPRIL 4MG CAPSULE Discontinued 2020-07-10 2020-07-10 120030
TEVA-PREGABALIN 75MG CAPSULE Discontinued 2020-07-10 2020-07-10 120033
ACT CELECOXIB 100MG CAPSULE To be discontinued 2020-09-03 2020-09-03 123648
ACT CELECOXIB 200MG CAPSULE To be discontinued 2020-09-03 2020-09-03 123651
TEVA-QUININE 200MG CAPSULE Discontinued 2020-10-08 2020-10-09 125976
TEVA-CEPHALEXIN 500MG CAPSULE Discontinued 2020-10-08 2020-10-09 125979
ACT NABILONE 0.5MG CAPSULE Discontinued 2020-10-15 2020-10-15 126452
ACT CELECOXIB 200MG CAPSULE Discontinued 2021-02-12 2021-02-12 133874
ACT CELECOXIB 100MG CAPSULE Discontinued 2021-02-12 2021-02-12 133880
ACT NABILONE 0.5MG CAPSULE Discontinued 2021-09-23 2021-09-23 146066
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
TEVA-CIPROFLOXACIN Discontinued 2018-10-12 2018-10-12 63952
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64520

Showing 201 to 220 of 250